home > epc

European Pharmaceutical Contractor


European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.

Industry Advisers

Set up in December 2009, EPC’s board of Industry Advisers help develop the content of the magazine, using first-hand experience to keep the magazine focused on the latest developments in the industry.

Anne Maria Ylisaari
Senior Manager, Global Clinical Alliances & Sourcing
Orion Pharma Development

Beatrijs Van Liedekerke
Director, Advisory Services

Henrietta Ukwu
Senior Vice President, Global Regulatory Affairs
PPD, Inc

Jane Clarke
Director, eTMF Document Solutions and System Development

For further information please contact:

Jonathan Smith

Aimee-Rose O'Driscoll

We're also on Twitter! Follow us @EPCmagazine

View the digital version of EPC

Featured in this issue
Clinical Trials
Global Clinical Trials

Think Big

Operating in a global landscape means that clinical research has to consider a host of issues around ethics, contracts, logistics, start-up and data collection, says Rick Morrison from Comprehend Systems.
In Conclusion

No Kidding

Graham Hughes
comments on government plans to ban smoking in cars carrying children in England, and a call to update European requirements for paediatric trials.
  Marketplace & Business
Sponsor-CRO Collaborations

Double Impact

With the demands of global biopharma hitting unprecedented levels, the need to truly evolve the sponsor-CRO relationship and shed reliance on traditional, limited outsourcing models is becoming an imperative. Andrew Townshend and Judy Swilley at INC Research report.

Edited by
Dr Graham Hughes,
Consultant in
Published quarterly in
March, June,
September and December

Banner of ESMO.EPC on Samedan
Banner of Woodley.EPC on Samedan
Industry Events


14-15 July 2014, Holiday Inn Regents Park, London, UK

SMi is launching its inaugural Immunogenicity Conference, taking place in London on the 14th and 15th July. This two day event is designed to enhance SMi’s portfolio of pharmaceutical conferences, especially with a growing demand for biologic therapeutics.
More info >>

News and Press Releases

Synergy appoints John Barker as COO

Synergy Research Group, a Russia-based CRO is pleased to announce that John Barker has joined the company as COO as of February 1, 2014. John’s role will be focused on expanding Synergy’s growing business into clients in the USA.
More info >>

air transport logo


White Papers

The EC Definition of a Nanomaterial - Potential Measurement Methodologies


In October 2011 the European Commission published a definition of Nanomaterials. This move followed more than six years of scientific consideration of the potential toxicological and environmental challenges posed by engineered nanomaterials.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement